Steven S Welc1,2, Michelle Wehling-Henricks1, Makoto Kuro-O3, Kyle A Thomas1, James G Tidball1,4,5. 1. Department of Integrative Biology and Physiology, University of California, Los Angeles, CA, 90095, USA. 2. Indiana University School of Medicine, Indianapolis, IN, 46202, USA. 3. Division of Anti-Aging Medicine, Center for Molecular Medicine Jichi Medical University, 3311-1 Yakushiji Shimotsuke, Tochigi, 329-0498, Japan. 4. Molecular, Cellular & Integrative Physiology Program, University of California, Los Angeles, CA, 90095, USA. 5. Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, 90095, USA.
Abstract
NEW FINDINGS: What is the central question of this study? Does modulating the expression of Klotho affect myogenesis following acute injury of healthy, non-senescent muscle? What is the main finding and its importance? Klotho can accelerate muscle growth following acute injury of healthy, adult mice, which supports the possibility that increased delivery of Klotho could have therapeutic value for improving repair of damaged muscle. ABSTRACT: Skeletal muscle injuries activate a complex programme of myogenesis that can restore normal muscle structure. We tested whether modulating the expression of klotho influenced the response of mouse muscles to acute injury. Our findings show that klotho expression in muscle declines at 3 days post-injury. That reduction in klotho expression coincided with elevated expression of targets of Wnt signalling (Ccnd1; Myc) and increased MyoD+ muscle cell numbers, reflecting the onset of myogenic cell differentiation. klotho expression subsequently increased at 7 days post-injury with elevated expression occurring primarily in inflammatory lesions, which was accompanied by reduced expression of Wnt target genes (Ccnd1: 91%; Myc: 96%). Introduction of a klotho transgene maintained high levels of klotho expression over the course of muscle repair and attenuated the increases in Ccnd1 and Myc expression that occurred at 3 days post-injury. Correspondingly, transgene expression reduced Wnt signalling in Pax7+ cells, reflected by reductions in Pax7+ cells expressing active β-catenin, and reduced the numbers of MyoD+ cells at 3 days post-injury. At 21 days post-injury, muscles in klotho transgenic mice showed increased Pax7+ and decreased myogenin+ cell densities and large increases in myofibre size. Likewise, treating myogenic cells in vitro with Klotho reduced Myod expression but did not affect Pax7 expression. Muscle inflammation was only slightly modulated by increased klotho expression, initially reducing the expression of M2-biased macrophage markers Cd163 and Cd206 at 3 days post-injury and later increasing the expression of pan-macrophage marker F480 and Cd68 at 21 days post-injury. Collectively, our study shows that Klotho modulates myogenesis and that increased expression accelerates muscle growth after injury.
NEW FINDINGS: What is the central question of this study? Does modulating the expression of Klotho affect myogenesis following acute injury of healthy, non-senescent muscle? What is the main finding and its importance? Klotho can accelerate muscle growth following acute injury of healthy, adult mice, which supports the possibility that increased delivery of Klotho could have therapeutic value for improving repair of damaged muscle. ABSTRACT: Skeletal muscle injuries activate a complex programme of myogenesis that can restore normal muscle structure. We tested whether modulating the expression of klotho influenced the response of mouse muscles to acute injury. Our findings show that klotho expression in muscle declines at 3 days post-injury. That reduction in klotho expression coincided with elevated expression of targets of Wnt signalling (Ccnd1; Myc) and increased MyoD+ muscle cell numbers, reflecting the onset of myogenic cell differentiation. klotho expression subsequently increased at 7 days post-injury with elevated expression occurring primarily in inflammatory lesions, which was accompanied by reduced expression of Wnt target genes (Ccnd1: 91%; Myc: 96%). Introduction of a klotho transgene maintained high levels of klotho expression over the course of muscle repair and attenuated the increases in Ccnd1 and Myc expression that occurred at 3 days post-injury. Correspondingly, transgene expression reduced Wnt signalling in Pax7+ cells, reflected by reductions in Pax7+ cells expressing active β-catenin, and reduced the numbers of MyoD+ cells at 3 days post-injury. At 21 days post-injury, muscles in klotho transgenic mice showed increased Pax7+ and decreased myogenin+ cell densities and large increases in myofibre size. Likewise, treating myogenic cells in vitro with Klotho reduced Myod expression but did not affect Pax7 expression. Muscle inflammation was only slightly modulated by increased klotho expression, initially reducing the expression of M2-biased macrophage markers Cd163 and Cd206 at 3 days post-injury and later increasing the expression of pan-macrophage marker F480 and Cd68 at 21 days post-injury. Collectively, our study shows that Klotho modulates myogenesis and that increased expression accelerates muscle growth after injury.
Authors: Stephen A Bustin; Vladimir Benes; Jeremy A Garson; Jan Hellemans; Jim Huggett; Mikael Kubista; Reinhold Mueller; Tania Nolan; Michael W Pfaffl; Gregory L Shipley; Jo Vandesompele; Carl T Wittwer Journal: Clin Chem Date: 2009-02-26 Impact factor: 8.327
Authors: Shigehiro Doi; Yonglong Zou; Osamu Togao; Johanne V Pastor; George B John; Lei Wang; Kazuhiro Shiizaki; Russell Gotschall; Susan Schiavi; Noriaki Yorioka; Masaya Takahashi; David A Boothman; Makoto Kuro-O Journal: J Biol Chem Date: 2011-01-05 Impact factor: 5.157
Authors: Christopher S Fry; Jonah D Lee; Jyothi Mula; Tyler J Kirby; Janna R Jackson; Fujun Liu; Lin Yang; Christopher L Mendias; Esther E Dupont-Versteegden; John J McCarthy; Charlotte A Peterson Journal: Nat Med Date: 2014-12-15 Impact factor: 53.440
Authors: Hellen E Ahrens; Judith Huettemeister; Manuel Schmidt; Christoph Kaether; Julia von Maltzahn Journal: Skelet Muscle Date: 2018-07-04 Impact factor: 4.912
Authors: Steven S Welc; Michelle Wehling-Henricks; Jacqueline Antoun; Tracey T Ha; Isabella Tous; James G Tidball Journal: J Immunol Date: 2020-08-19 Impact factor: 5.422
Authors: James G Tidball; Ivan Flores; Steven S Welc; Michelle Wehling-Henricks; Eisuke Ochi Journal: Exp Gerontol Date: 2020-12-24 Impact factor: 4.032
Authors: Yi Zhu; Larissa G P Langhi Prata; Erin O Wissler Gerdes; Jair Machado Espindola Netto; Tamar Pirtskhalava; Nino Giorgadze; Utkarsh Tripathi; Christina L Inman; Kurt O Johnson; Ailing Xue; Allyson K Palmer; Tingjun Chen; Kalli Schaefer; Jamie N Justice; Anoop M Nambiar; Nicolas Musi; Stephen B Kritchevsky; Jun Chen; Sundeep Khosla; Diana Jurk; Marissa J Schafer; Tamar Tchkonia; James L Kirkland Journal: EBioMedicine Date: 2022-03-13 Impact factor: 11.205
Authors: Natasha L McRae; Alex B Addinsall; Kirsten F Howlett; Bryony McNeill; Daniel R McCulloch; Nicole Stupka Journal: Sci Rep Date: 2020-07-06 Impact factor: 4.379
Authors: Walter H Moos; Douglas V Faller; Ioannis P Glavas; David N Harpp; Iphigenia Kanara; Anastasios N Mavrakis; Julie Pernokas; Mark Pernokas; Carl A Pinkert; Whitney R Powers; Konstantina Sampani; Kosta Steliou; Demetrios G Vavvas; Robert J Zamboni; Krishna Kodukula; Xiaohong Chen Journal: Biores Open Access Date: 2020-03-31
Authors: Cynthia M McKee; Douglas J Chapski; Michelle Wehling-Henricks; Manuel Rosa-Garrido; Makoto Kuro-O; Thomas M Vondriska; James G Tidball Journal: FASEB J Date: 2022-03 Impact factor: 5.834